Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-01 4:15 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 4,435,534 9.800% | 146,341 (+3.41%) | View |
| 2024-05-17 5:13 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 4,289,193 11.200% | 1,492,915 (+53.39%) | View |
| 2024-03-22 6:24 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,796,278 7.500% | 352,039 (+14.40%) | View |
| 2024-02-14 2:24 pm Purchase | 13G | CHECKPOINT THERAPEUTICS INC CO CKPT | ARMISTICE CAPITAL LLC | 2,715,635 9.990% | 1,728,424 (+175.08%) | View |
| 2023-09-26 4:16 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,444,239 11.300% | 80,906 (+3.42%) | View |
| 2023-07-06 4:44 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,363,333 13.600% | 81,406 (+3.57%) | View |
| 2023-04-19 4:24 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,281,927 17.500% | 78,214 (+3.55%) | View |
| 2023-02-14 12:23 pm Purchase | 13G | CHECKPOINT THERAPEUTICS INC CO CKPT | ARMISTICE CAPITAL LLC | 987,211 9.990% | 987,211 (New Position) | View |
| 2023-01-13 4:13 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,203,713 19.300% | 2,203,713 (New Position) | View |
| 2021-05-07 5:09 pm Purchase | 13G | CHECKPOINT THERAPEUTICS INC CO CKPT | BlackRock Inc. BLK | 3,487,614 4.800% | 247,015 (+7.62%) | View |
| 2021-02-16 09:56 am Sale | 13G | CHECKPOINT THERAPEUTICS INC CO CKPT | CVI Investments Inc. | 636,964 1.000% | -2,934,465 (-82.17%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | CHECKPOINT THERAPEUTICS INC CO CKPT | BlackRock Inc. BLK | 3,240,599 5.300% | 1,799,741 (+124.91%) | View |
| 2021-01-07 09:18 am Sale | 13G | CHECKPOINT THERAPEUTICS INC CO CKPT | SABBY MANAGEMENT LLC | 0 0.000% | -3,571,428 (Position Closed) | View |
| 2020-09-25 10:08 am Purchase | 13G | CHECKPOINT THERAPEUTICS INC CO CKPT | CVI Investments Inc. | 3,571,429 5.500% | 3,571,429 (New Position) | View |
| 2020-09-18 10:10 am Purchase | 13G | CHECKPOINT THERAPEUTICS INC CO CKPT | SABBY MANAGEMENT LLC | 3,571,428 11.000% | 3,571,428 (New Position) | View |
| 2019-12-10 1:22 pm Sale | 13G | CHECKPOINT THERAPEUTICS INC CO CKPT | BlackRock Inc. BLK | 1,440,858 3.200% | -194,101 (-11.87%) | View |